Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

Overview of attention for article published in JAMA Network Open, March 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 1 Facebook page

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 1 X post from an account with 26,154 followers.

Cohort study delineates early US experience with peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors and finds significantly longer PFS for patients with small bowel NETs as compared to pancreatic NETs. @PennMedicine …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.